| SABADELL ESTADOS UNIDOS BOLSA, FI EMPRESA | RVI USA | 40,71% | 41,73% | 106,67% | · |
| GOLDMAN SACHS US ENHANCED EQUITY I CAP USD | RVI USA | 41,61% | 50,16% | 106,66% | 272,23% |
| JPM GLOBAL SELECT EQUITY I (ACC) USD | RVI GLOBAL | 29,73% | 45,69% | 106,55% | · |
| GOLDMAN SACHS US CORE EQUITY PORTFOLIO P (SNAP) USD DIS | RVI USA | 39,85% | 43,03% | 106,54% | 255,38% |
| AMUNDI INDEX MSCI NORTH AMERICA ESG BROAD CTB RU CAP | RVI USA | 37,97% | 40,24% | 106,53% | 267,47% |
| SCHRODER ISF GLOBAL EQUITY ALPHA I ACC EUR | RVI GLOBAL VALOR | 31,82% | 37,87% | 106,52% | 234,63% |
| POLAR CAPITAL BIOTECHNOLOGY S GBP DIS | BIOTECNOLOGÍA | 42,10% | 35,61% | 106,51% | 292,69% |
| CT (LUX) US CONTRARIAN CORE EQUITIES AU USD | RVI USA | 35,07% | 44,02% | 106,47% | 238,05% |
| BROWN ADVISORY US FLEXIBLE EQUITY A USD ACC | RVI USA | 37,53% | 44,20% | 106,42% | · |
| MAN GLG JAPAN COREALPHA EQUITY IXX H EUR | RVI JAPÓN | 19,53% | 94,62% | 106,34% | · |
